Archives
Ibotenic Acid in Pain-Circuit Research Workflows
2026-09-09
Use Ibotenic acid as a controlled NMDA receptor agonist for region-level perturbation, excitotoxic lesion studies, and glutamatergic circuit validation. This workflow-focused guide shows how to connect focal chemical manipulation with behavioral phenotyping while avoiding the interpretive errors that arise when broad neuronal injury is mistaken for cell-type specificity.
Q-VD(OMe)-OPh in Apoptosis Research
2026-09-08
Q-VD(OMe)-OPh is a broad-spectrum pan-caspase inhibitor for controlled apoptosis modulation. Its reported activity against recombinant caspases and low reported cytotoxicity support applications in apoptosis assays, acute myeloid leukemia differentiation, and neuroprotection in ischemic stroke models.
NU7441 Workflows for DNA-PK Research
2026-09-07
NU7441 (KU-57788) gives researchers a selective way to interrogate DNA-PK-dependent repair, cell-cycle responses, and treatment sensitization. This practical guide connects assay design, dosing, controls, and troubleshooting for DNA repair research and oncology research.
Structural Tuning of CD38 CAR Binders
2026-09-07
Cheng et al. define how two CD38-targeting CAR binders engage distinct antigen surfaces and differentially affect CD38 enzymatic activity. The study links structural epitope recognition with affinity tuning, reduced CAR-T fratricide, and preserved antitumor cytotoxicity, providing a framework for designing more selective CD38-directed therapies.
Tetrandrine N1798: Reliable Cell Assay Design
2026-09-05
Learn how Tetrandrine (SKU N1798) can be incorporated into cell viability, proliferation, and ion channel workflows while controlling solubility, vehicle, and interpretation risks. This scenario-based guide connects product specifications with practical assay design and evidence-aware data analysis.
Liproxstatin-1 Workflow for Ferroptosis Research
2026-09-04
Liproxstatin-1 is a nanomolar ferroptosis inhibitor for separating lipid peroxidation-driven death from apoptosis, oxidative stress, and copper-associated cytotoxicity. This practical guide covers cell-based rescue assays, GPX4-deficient cell protection, renal injury workflows, assay controls, and troubleshooting.
Coumestrol, PMAIP1, and Ferroptosis in RA
2026-09-04
A 2026 study identifies a PMAIP1-dependent ferroptosis mechanism through which Coumestrol suppresses rheumatoid arthritis fibroblast-like synoviocyte proliferation and inflammatory signaling. The work connects TRIM3-mediated protein stability, mitochondrial stress, and iron accumulation, while providing a useful in vitro framework for evaluating this compound beyond its established estrogen receptor pharmacology.
Ionomycin calcium salt: Calcium Signaling Workflows
2026-09-03
Ionomycin calcium salt provides a practical way to raise intracellular Ca2+ and connect calcium dynamics with secretion, protein regulation, viability, and apoptosis assays. This workflow-focused guide shows how to build controlled calcium perturbation experiments while using the malignant pleural mesothelioma literature to improve assay stratification without overstating translational evidence.
BMS-345541 Hydrochloride in Cell-Fate Research
2026-09-03
BMS-345541 hydrochloride is an allosteric IKK inhibitor that can separate NF-κB transcriptional survival signals from RIPK1-driven cell death. This article presents a pathway-aware framework for inflammation research, T-ALL apoptosis studies, and mechanistically resolved assay design.
Podophyllotoxin Derivative 5p and MDR
2026-09-02
The reference study shows that podophyllotoxin derivative 5p combines catalytic topoisomerase IIα inhibition with suppression of microtubule polymerization, producing activity against several multidrug-resistant cancer models. Its effects connect target inhibition with G2/M arrest, apoptosis, pyroptosis, reduced drug-efflux protein expression, and impaired resistant-tumor growth in xenografts.
Aztreonam for Reliable Cell and Microbial Assays
2026-09-02
Aztreonam (SKU A5931) supports mechanism-aware Gram-negative research while highlighting critical controls for cell viability, progenitor-cell, and hepatic enzyme studies. This scenario-driven guide covers interpretation, solution preparation, assay compatibility, and practical supplier selection.
Leucovorin Calcium in Antifolate Assays
2026-09-01
Leucovorin Calcium enables controlled methotrexate-rescue experiments in cell lines, organoids, and tumor–stroma assembloids. This workflow uses calcium folinate to separate folate-pathway protection from microenvironment-driven drug resistance, improving the interpretability of viability and proliferation data.
Triamcinolone B1859: In Vitro Workflow Guide
2026-09-01
Triamcinolone B1859 provides a defined synthetic glucocorticoid agonist for controlled studies of glucocorticoid signaling, inflammation, and immunosuppression. This guide explains preparation, assay controls, QC, and handling boundaries for research use; it is not intended for diagnostic, therapeutic, or clinical applications.
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-08-31
The reference study developed chemically modified p21 mRNA packaged in lipid nanoparticles for localized intravesical treatment of bladder cancer. Its preclinical data connect restored nuclear p21 expression with cell-cycle inhibition, DNA-damage signaling, apoptosis, and reduced tumor growth, while also highlighting delivery and manufacturing questions for future translation.
WAY-100635: A Causal Probe for Pain Circuits
2026-08-31
WAY-100635 enables precise serotonin receptor antagonist research by testing whether 5-HT1A signaling contributes to sensory, affective, and cognitive pain phenotypes. This article presents an assay-centered framework that extends cannabidiol findings without overstating serotonergic mechanism.
699 records 8/47 page Previous Next First page 上5页 678910 下5页 Last page